Christopher Hardy Fanta, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 30 | 2022 | 6195 | 1.290 |
Why?
|
| Anti-Asthmatic Agents | 5 | 2022 | 571 | 1.050 |
Why?
|
| Bronchodilator Agents | 9 | 2022 | 512 | 0.590 |
Why?
|
| Gastroesophageal Reflux | 1 | 2022 | 816 | 0.490 |
Why?
|
| Tracheomalacia | 2 | 2012 | 63 | 0.490 |
Why?
|
| Adrenal Cortex Hormones | 4 | 2022 | 1874 | 0.450 |
Why?
|
| Immunocompetence | 1 | 2013 | 138 | 0.420 |
Why?
|
| Leukotriene Antagonists | 1 | 2009 | 124 | 0.310 |
Why?
|
| Bronchi | 7 | 2012 | 845 | 0.270 |
Why?
|
| Nifedipine | 6 | 1987 | 221 | 0.270 |
Why?
|
| Administration, Inhalation | 3 | 2022 | 1156 | 0.260 |
Why?
|
| Lung Diseases | 3 | 2013 | 1909 | 0.250 |
Why?
|
| Respiratory Tract Infections | 1 | 2013 | 1010 | 0.240 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2009 | 1240 | 0.210 |
Why?
|
| Bone Diseases | 2 | 2019 | 419 | 0.210 |
Why?
|
| Muscarinic Antagonists | 1 | 2022 | 135 | 0.200 |
Why?
|
| Sarcoidosis | 2 | 2019 | 521 | 0.190 |
Why?
|
| Sublingual Gland | 1 | 1999 | 11 | 0.170 |
Why?
|
| Pollen | 1 | 1999 | 81 | 0.170 |
Why?
|
| Antibodies, Anti-Idiotypic | 2 | 2012 | 357 | 0.160 |
Why?
|
| Sarcoidosis, Pulmonary | 1 | 2019 | 45 | 0.160 |
Why?
|
| Adrenergic beta-Agonists | 3 | 1996 | 344 | 0.160 |
Why?
|
| Status Asthmaticus | 1 | 1998 | 22 | 0.150 |
Why?
|
| Calcium Channel Blockers | 4 | 1985 | 694 | 0.150 |
Why?
|
| Theophylline | 4 | 1986 | 131 | 0.140 |
Why?
|
| Horses | 1 | 1998 | 300 | 0.140 |
Why?
|
| Milk Hypersensitivity | 1 | 1998 | 78 | 0.140 |
Why?
|
| Mouth Mucosa | 1 | 1999 | 430 | 0.140 |
Why?
|
| Glucocorticoids | 5 | 2019 | 2163 | 0.130 |
Why?
|
| Milk | 1 | 1998 | 443 | 0.120 |
Why?
|
| Drug Therapy, Combination | 5 | 2022 | 6297 | 0.120 |
Why?
|
| Allergens | 2 | 1999 | 1410 | 0.120 |
Why?
|
| Albuterol | 3 | 1996 | 213 | 0.120 |
Why?
|
| Bronchial Spasm | 2 | 1985 | 71 | 0.120 |
Why?
|
| Pulmonary Atelectasis | 2 | 2012 | 143 | 0.110 |
Why?
|
| Isoproterenol | 5 | 1987 | 395 | 0.110 |
Why?
|
| SRS-A | 1 | 1992 | 132 | 0.100 |
Why?
|
| Dyspnea | 3 | 2012 | 1344 | 0.100 |
Why?
|
| Ambulatory Care | 3 | 2019 | 2771 | 0.100 |
Why?
|
| Disease Management | 2 | 2012 | 2501 | 0.100 |
Why?
|
| Cough | 2 | 2012 | 594 | 0.090 |
Why?
|
| Aminophylline | 4 | 1986 | 41 | 0.090 |
Why?
|
| Telemedicine | 2 | 2019 | 3027 | 0.090 |
Why?
|
| IgA Deficiency | 1 | 2011 | 43 | 0.090 |
Why?
|
| Thymus Hyperplasia | 1 | 2011 | 32 | 0.090 |
Why?
|
| Forced Expiratory Volume | 10 | 2012 | 1812 | 0.090 |
Why?
|
| Lung Diseases, Obstructive | 2 | 1982 | 308 | 0.090 |
Why?
|
| Ikaros Transcription Factor | 1 | 2011 | 232 | 0.080 |
Why?
|
| Immunoglobulin E | 2 | 2009 | 1494 | 0.080 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2011 | 226 | 0.080 |
Why?
|
| Humans | 49 | 2022 | 760437 | 0.070 |
Why?
|
| Diagnosis, Differential | 7 | 2012 | 12969 | 0.070 |
Why?
|
| Respiration, Artificial | 1 | 1998 | 2622 | 0.070 |
Why?
|
| Respiration | 4 | 1995 | 1657 | 0.070 |
Why?
|
| Bronchoscopy | 1 | 2012 | 909 | 0.070 |
Why?
|
| Trachea | 5 | 1985 | 1089 | 0.070 |
Why?
|
| Muscle, Smooth | 4 | 1985 | 926 | 0.070 |
Why?
|
| Drug Resistance | 1 | 2012 | 1597 | 0.070 |
Why?
|
| Mucus | 2 | 1985 | 341 | 0.060 |
Why?
|
| Epinephrine | 3 | 1986 | 792 | 0.060 |
Why?
|
| Acute Disease | 7 | 1998 | 7230 | 0.060 |
Why?
|
| Verapamil | 1 | 1985 | 242 | 0.060 |
Why?
|
| Asthma, Exercise-Induced | 2 | 1985 | 23 | 0.060 |
Why?
|
| Immunotherapy | 1 | 1999 | 4649 | 0.060 |
Why?
|
| Bone and Bones | 1 | 2014 | 2566 | 0.060 |
Why?
|
| Respiratory System | 2 | 1985 | 563 | 0.050 |
Why?
|
| Physical Education and Training | 1 | 1983 | 101 | 0.050 |
Why?
|
| Inflammation | 1 | 2022 | 10746 | 0.050 |
Why?
|
| Radiography | 2 | 2012 | 6963 | 0.050 |
Why?
|
| Adult | 28 | 2019 | 220781 | 0.050 |
Why?
|
| Killer Cells, Natural | 1 | 2011 | 2202 | 0.050 |
Why?
|
| Emergencies | 4 | 1995 | 1217 | 0.050 |
Why?
|
| Pulmonary Heart Disease | 1 | 1981 | 34 | 0.050 |
Why?
|
| Respiratory Hypersensitivity | 2 | 1998 | 273 | 0.050 |
Why?
|
| Quality of Life | 1 | 2022 | 13338 | 0.050 |
Why?
|
| Cromolyn Sodium | 1 | 1981 | 77 | 0.050 |
Why?
|
| Random Allocation | 5 | 1986 | 2388 | 0.040 |
Why?
|
| Hernia | 1 | 1980 | 68 | 0.040 |
Why?
|
| Poaceae | 1 | 1999 | 25 | 0.040 |
Why?
|
| Mast Cells | 2 | 1985 | 1391 | 0.040 |
Why?
|
| Bronchial Provocation Tests | 3 | 1985 | 216 | 0.040 |
Why?
|
| Oropharynx | 1 | 1980 | 138 | 0.040 |
Why?
|
| Hernia, Diaphragmatic | 1 | 1980 | 246 | 0.040 |
Why?
|
| Body Temperature Regulation | 1 | 1981 | 292 | 0.040 |
Why?
|
| Airway Obstruction | 3 | 1995 | 661 | 0.040 |
Why?
|
| Guinea Pigs | 3 | 1987 | 1317 | 0.040 |
Why?
|
| Female | 28 | 2019 | 391875 | 0.040 |
Why?
|
| Radioallergosorbent Test | 1 | 1998 | 19 | 0.040 |
Why?
|
| Muscles | 1 | 1983 | 1575 | 0.040 |
Why?
|
| Lung | 4 | 2012 | 9973 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2011 | 4748 | 0.040 |
Why?
|
| Pleural Effusion | 1 | 1980 | 342 | 0.040 |
Why?
|
| Antirheumatic Agents | 2 | 2019 | 1371 | 0.030 |
Why?
|
| Ipratropium | 1 | 1996 | 19 | 0.030 |
Why?
|
| Ventilator Weaning | 1 | 1998 | 163 | 0.030 |
Why?
|
| Prognosis | 2 | 2013 | 29551 | 0.030 |
Why?
|
| Peak Expiratory Flow Rate | 2 | 1995 | 144 | 0.030 |
Why?
|
| Cold Temperature | 3 | 1985 | 786 | 0.030 |
Why?
|
| Cross Reactions | 1 | 1998 | 818 | 0.030 |
Why?
|
| Clone Cells | 1 | 1999 | 1660 | 0.030 |
Why?
|
| Skin Tests | 1 | 1998 | 637 | 0.030 |
Why?
|
| Male | 28 | 2019 | 360035 | 0.030 |
Why?
|
| Geriatrics | 1 | 2000 | 388 | 0.030 |
Why?
|
| Interleukin-4 | 1 | 1999 | 1130 | 0.030 |
Why?
|
| Lung Compliance | 2 | 1987 | 200 | 0.030 |
Why?
|
| Histamine | 3 | 1987 | 497 | 0.030 |
Why?
|
| Muscle Contraction | 3 | 1985 | 1197 | 0.030 |
Why?
|
| Incidence | 1 | 2013 | 21322 | 0.030 |
Why?
|
| Time Factors | 6 | 2019 | 39947 | 0.030 |
Why?
|
| Airway Resistance | 2 | 1987 | 406 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 7424 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2004 | 2318 | 0.030 |
Why?
|
| Pneumonia | 2 | 1982 | 2140 | 0.030 |
Why?
|
| Age of Onset | 1 | 2000 | 3302 | 0.030 |
Why?
|
| Pyridines | 2 | 1983 | 2868 | 0.030 |
Why?
|
| Fever | 1 | 1981 | 1618 | 0.030 |
Why?
|
| Prednisone | 2 | 2014 | 1564 | 0.030 |
Why?
|
| Obesity | 2 | 2012 | 12918 | 0.030 |
Why?
|
| Middle Aged | 17 | 2019 | 220382 | 0.030 |
Why?
|
| Bronchiectasis | 1 | 1994 | 139 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1999 | 1841 | 0.030 |
Why?
|
| Leukotriene E4 | 1 | 1992 | 75 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2009 | 9176 | 0.020 |
Why?
|
| Liver Diseases | 1 | 1980 | 1296 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 1999 | 3157 | 0.020 |
Why?
|
| Calcium | 1 | 1984 | 5726 | 0.020 |
Why?
|
| Blotting, Western | 1 | 1998 | 5031 | 0.020 |
Why?
|
| Hydroxychloroquine | 1 | 2014 | 426 | 0.020 |
Why?
|
| Lung Volume Measurements | 2 | 1981 | 375 | 0.020 |
Why?
|
| Adolescent | 11 | 2011 | 88196 | 0.020 |
Why?
|
| Hypertension, Pulmonary | 1 | 1980 | 1580 | 0.020 |
Why?
|
| Hospitals, Teaching | 1 | 2014 | 1155 | 0.020 |
Why?
|
| Thymoma | 1 | 2011 | 187 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 1999 | 5865 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2019 | 5236 | 0.020 |
Why?
|
| Thymus Neoplasms | 1 | 2011 | 273 | 0.020 |
Why?
|
| Sputum | 2 | 1994 | 506 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2014 | 1807 | 0.020 |
Why?
|
| Respiratory Sounds | 1 | 2012 | 701 | 0.020 |
Why?
|
| Biopsy | 2 | 2014 | 6765 | 0.020 |
Why?
|
| Lung Neoplasms | 3 | 1981 | 13312 | 0.020 |
Why?
|
| Methotrexate | 1 | 2014 | 1720 | 0.020 |
Why?
|
| Pulmonary Embolism | 1 | 1981 | 2563 | 0.020 |
Why?
|
| Aged | 7 | 2017 | 168840 | 0.020 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1982 | 3610 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 1995 | 2133 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2019 | 64591 | 0.020 |
Why?
|
| Self Report | 1 | 2017 | 3721 | 0.020 |
Why?
|
| Age Factors | 2 | 2019 | 18379 | 0.020 |
Why?
|
| Clinical Trials as Topic | 4 | 1986 | 7996 | 0.020 |
Why?
|
| Terbutaline | 1 | 1985 | 23 | 0.020 |
Why?
|
| Expectorants | 1 | 1985 | 22 | 0.020 |
Why?
|
| Social Class | 1 | 1994 | 2003 | 0.020 |
Why?
|
| Double-Blind Method | 3 | 1996 | 12320 | 0.010 |
Why?
|
| Viscosity | 1 | 1985 | 336 | 0.010 |
Why?
|
| Histamine Release | 1 | 1984 | 135 | 0.010 |
Why?
|
| Animals | 7 | 2011 | 168253 | 0.010 |
Why?
|
| Pituitary-Adrenal Function Tests | 1 | 1983 | 30 | 0.010 |
Why?
|
| Constriction, Pathologic | 1 | 1987 | 1097 | 0.010 |
Why?
|
| Acetylcysteine | 1 | 1985 | 260 | 0.010 |
Why?
|
| Chemotactic Factors | 1 | 1984 | 197 | 0.010 |
Why?
|
| Total Lung Capacity | 1 | 1983 | 149 | 0.010 |
Why?
|
| Respiratory Function Tests | 2 | 1994 | 1681 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1987 | 10759 | 0.010 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 1983 | 189 | 0.010 |
Why?
|
| Body Temperature | 1 | 1985 | 779 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1987 | 1337 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 1999 | 10188 | 0.010 |
Why?
|
| Delayed-Action Preparations | 1 | 1985 | 961 | 0.010 |
Why?
|
| Disease Progression | 1 | 2019 | 13484 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2011 | 2531 | 0.010 |
Why?
|
| Phenotype | 1 | 1999 | 16585 | 0.010 |
Why?
|
| Carbachol | 1 | 1982 | 223 | 0.010 |
Why?
|
| Respiratory Therapy | 1 | 1982 | 125 | 0.010 |
Why?
|
| Nocardia Infections | 1 | 1981 | 19 | 0.010 |
Why?
|
| Ethanol | 1 | 1987 | 1324 | 0.010 |
Why?
|
| Cilia | 1 | 1985 | 494 | 0.010 |
Why?
|
| Bronchitis | 1 | 1981 | 196 | 0.010 |
Why?
|
| Vital Capacity | 1 | 1983 | 970 | 0.010 |
Why?
|
| Plethysmography | 1 | 1980 | 175 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2017 | 4789 | 0.010 |
Why?
|
| Biological Transport | 1 | 1985 | 2090 | 0.010 |
Why?
|
| Lung Diseases, Fungal | 1 | 1981 | 126 | 0.010 |
Why?
|
| Efferent Pathways | 1 | 1980 | 165 | 0.010 |
Why?
|
| Awareness | 1 | 2004 | 647 | 0.010 |
Why?
|
| Dogs | 1 | 1985 | 3839 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 1998 | 15820 | 0.010 |
Why?
|
| Aerosols | 1 | 1982 | 631 | 0.010 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1981 | 242 | 0.010 |
Why?
|
| Antigens | 1 | 1985 | 1446 | 0.010 |
Why?
|
| Self Care | 1 | 2004 | 794 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 1994 | 4316 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1994 | 3759 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2014 | 39078 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1986 | 4010 | 0.010 |
Why?
|
| Kinetics | 1 | 1985 | 6377 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1985 | 4849 | 0.010 |
Why?
|
| Lidocaine | 1 | 1980 | 540 | 0.010 |
Why?
|
| Spirometry | 1 | 1980 | 928 | 0.010 |
Why?
|
| Autopsy | 1 | 1981 | 1005 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2004 | 1534 | 0.010 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 1981 | 677 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1981 | 1975 | 0.010 |
Why?
|
| Placebos | 1 | 1981 | 1661 | 0.010 |
Why?
|
| Urban Population | 1 | 2004 | 2032 | 0.010 |
Why?
|
| Beclomethasone | 1 | 1995 | 38 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2004 | 2493 | 0.010 |
Why?
|
| Sensory Receptor Cells | 1 | 1980 | 512 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2011 | 14397 | 0.010 |
Why?
|
| Triamcinolone | 1 | 1995 | 68 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 1983 | 1815 | 0.010 |
Why?
|
| Data Collection | 1 | 2004 | 3321 | 0.010 |
Why?
|
| Body Height | 1 | 1981 | 1570 | 0.010 |
Why?
|
| Risk Factors | 2 | 2019 | 74055 | 0.010 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 1981 | 831 | 0.010 |
Why?
|
| Methylprednisolone | 1 | 1995 | 384 | 0.010 |
Why?
|
| Pseudomonas | 1 | 1994 | 124 | 0.010 |
Why?
|
| Haemophilus influenzae | 1 | 1994 | 180 | 0.010 |
Why?
|
| Radiation Injuries | 1 | 1981 | 1185 | 0.010 |
Why?
|
| Cell Survival | 1 | 1982 | 5790 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 1981 | 1406 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2019 | 80430 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 1981 | 1938 | 0.010 |
Why?
|
| Smoking | 2 | 1995 | 9046 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 59068 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2004 | 8611 | 0.010 |
Why?
|
| Injections, Subcutaneous | 2 | 1981 | 678 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2011 | 23397 | 0.000 |
Why?
|
| Rats | 1 | 1983 | 23712 | 0.000 |
Why?
|
| Mutation | 1 | 2011 | 30025 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1981 | 9309 | 0.000 |
Why?
|
| Staphylococcus aureus | 1 | 1994 | 1459 | 0.000 |
Why?
|
| Hyperventilation | 1 | 1985 | 78 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 2 | 1994 | 20551 | 0.000 |
Why?
|
| Emergency Service, Hospital | 1 | 1983 | 7860 | 0.000 |
Why?
|
| Mice | 1 | 2011 | 81402 | 0.000 |
Why?
|
| Academic Medical Centers | 1 | 1994 | 2757 | 0.000 |
Why?
|
| Pneumonia, Viral | 1 | 1981 | 3200 | 0.000 |
Why?
|
| Self Administration | 1 | 1983 | 390 | 0.000 |
Why?
|
| Drug Tolerance | 1 | 1983 | 367 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1981 | 18216 | 0.000 |
Why?
|
| Insurance, Health | 1 | 1994 | 2491 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1986 | 54339 | 0.000 |
Why?
|
| Critical Care | 1 | 1994 | 2697 | 0.000 |
Why?
|
| Boston | 1 | 1994 | 9326 | 0.000 |
Why?
|
| Patient Discharge | 1 | 1994 | 3436 | 0.000 |
Why?
|
| Health Status | 1 | 1994 | 4071 | 0.000 |
Why?
|
| Comorbidity | 1 | 1994 | 10494 | 0.000 |
Why?
|
| Administration, Intranasal | 1 | 1980 | 477 | 0.000 |
Why?
|
| Injections, Intravenous | 1 | 1981 | 1379 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 1995 | 22097 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 1980 | 20985 | 0.000 |
Why?
|
| Cohort Studies | 1 | 1995 | 41366 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1995 | 58859 | 0.000 |
Why?
|
| United States | 1 | 1994 | 72202 | 0.000 |
Why?
|